CSI Market
Sign In | Register

Royalty Pharma Plc (RPRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RPRX Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Royalty Pharma Plc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent586.40
Available-for-sale Securities, Debt Securities, Current MA21.90
Cash & Short-term Investments607.00
Other Receivables0.00
Notes, Loans and Financing Receivable, Net, Current AC779.84
Other Current Assets37.67
Total Current Assets1,425.81
Goodwill net924.63
Long-term investments406.80
Notes, Loans and Financing Receivable, Net, Noncurrent LO16,542.35
Other Assets, Noncurrent922.62
Other Royalty Income Receivable Current27.51
Equity Securities F V N I Noncurrent173.27
Total Assets19,815.42
Liabilities
Accounts Payable and Accrued Liabilities, Current LI25.48
Interest Payable, Current IN25.30
Long-term Debt, Current Maturities LO380.00
Other Liabilities, Current104.90
Total Current Liabilities535.68
Long-term debt8,576.44
Long-term Debt Convertible0.00
Total Long-term Debt8,576.44
Due to Employees, Noncurrent766.46
Distributions Payable To Legacy Non Controlling Interests Current-
Total Liabilities9,878.58
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock4,384.06
Retained Earnings / Accumulated Deficit2,507.09
Other Equity-2.65
Common Stockholder's Equity6,888.55
Non-controlling interests & other3,048.29
Total Stockholder's Equity9,936.83
Liabilities & Stockholder's Equity19,815.42
4 historic quarters locked

Sign in to unlock the full Royalty Pharma Plc balance sheet history.

Sign In Create Free Account

About Royalty Pharma Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001802768-26-000015

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.